An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine. The ongoing Phase 1 trial is supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The experimental vaccine is being co-developed by researchers at NIAID and at Moderna, Inc. of Cambridge, Massachusetts. Manufactured by Moderna, mRNA-1273 is designed to induce neutralizing antibodies directed at a portion of the coronavirus “spike” protein, which the virus uses to bind to and enter human cells.
Heartland Alliance, one of the world’s leading anti-poverty organizations, works in communities in the U.S. and abroad to serve those who are homeless, living in poverty, or seeking safety. It provides a comprehensive array of services in the areas of health, housing, jobs and justice – and leads state and national policy efforts, which target lasting change for individuals and society.
Looking for a way to make a difference during the COVID-19 pandemic? Sign the petition below to mandate the provision of free menstrual products in shelters throughout the state of Illinois. Homeless menstruators are some of the most vulnerable people during this pandemic due to surges in domestic abuse and the inability to follow stay at home orders to allow them to stay safe and healthy. We are trying to provide them with the basic human right of access to free menstrual products so they can maintain their menstrual hygiene to prevent further exposure to COVID-19. No matter where you live, help make a difference by sharing and signing the petition below. Every signature counts! Together, let’s #freetheperiod! ✊📣❣️
EndingCOVID.org is a nonprofit initiative nested within TejHospitality, a registered 501(c)(3) charitable organization focused on local asset-based community development in the Greater St. Louis Area.